bibliographicCitation |
Pallerla S, Gauthier T, Sable R, Jois SD. Design of a doxorubicin-peptidomimetic conjugate that targets HER2-positive cancer cells. European Journal of Medicinal Chemistry. 2017 Jan;125():914–24. doi: 10.1016/j.ejmech.2016.10.015. |